RIGL

RIGL Net Income Growth

229.08%TTM

Period ending:

RIGL TTM Net Income YoY %%
RIGL TTM Net Income YoY %3276.86%-1450.76%
2001-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

RIGL net income growth history

Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 99 observations from Dec 31, 2001 to Jun 30, 2026.

Rigel Pharmaceuticals Inc Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
229.0796%
879.6977%
1,999.0792%
2,819.3507%
787.3314%
287.7487%
169.6863%
115.8882%
62.3213%
55.6645%
57.1629%
70.4327%
55.3153%
47.3668%
-226.9677%
-469.366%
-993.2488%
-638.7394%
39.7727%
47.6306%
69.1004%
59.0525%
55.5356%
40.3715%
57.4019%
55.9559%
5.088%
53.3376%
37.1562%
26.8426%
9.6318%
-47.0647%
-28.609%
-29.8169%
-12.6791%
-2.1082%
-44.3324%
-32.1888%
-34.494%
-8.6226%
33.143%
41.5482%
43.3889%
28.5952%
14.7773%
-1.2151%
-2.1128%
12.4347%
10.9711%
15.2944%
9.9282%
1.5299%
-8.3379%
-14.569%
-14.9663%
-28.0659%
-911.257%
-324.0404%
-326.9016%
-357.774%
80.7409%
137.9403%
133.9677%
125.068%
64.0465%
22.9975%
15.7156%
-1.5544%
-31.8641%
-59.8593%
-78.191%
-66.8184%
-57.1101%
-82.605%
-97.3377%
-127.6051%
-93.7665%
-8.6652%
16.8353%
39.1767%
39.9878%
21.7168%
19.552%
4.3116%
-12.4058%
-17.0513%
-36.5512%
-42.7376%
-32.4744%
-27.4014%
-11.253%
-6.6551%
-17.1119%
-30.1281%
-55.5556%
-49.4864%
-31.0226%
-21.8713%
6.1317%

Compare net income growth

Other companies in Health Care. Each page shows its own reporting periods and currency.

Compare all covered stocks by net income growth →

All RIGL financial metrics · RIGL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.